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INTRODUCTION
Endocarditis is one of the most serious complications of
intravenous drug use, although right sided IE may occur
in association with congenital heart disease and
instrumentation of the right heart. The incidence of Right-
Sided Endocarditis (RSE) amongst the intravenous drug
users stands at 5 - 10% per year.1 Being common in this
population RSE especially involves the tricuspid valve
with a propensity of high recurrence.2,3 RSE accounts
for 10% of all infective endocarditis in population based
surveys. Generally, RSE can be treated with carefully
tailored antimicrobial therapy against specific organism
which gives a high alleviation rate.3,4 However, this
treatment modality is readily rendered useless due to the
virulence of the organisms involved and their repeated
exposure to the inciting agent. It is in these cases that
surgery becomes the treatment of choice.
The purpose of presenting this interesting case is to
develop awareness among clinicians that long-term
survival of a patient without Tricuspid Valve (TV)
replacement is possible, particularly if the pulmonary
artery pressure is normal.
CASE REPORT
A 36-year woman with a history of repeated Intravenous
(IV) analgesic injections for low back pain, presented
with high grade fever and sepsis; and a count of 44,000
with 90% neutrophils, and admitted to the Aga Khan
Hospital, Karachi, Pakistan. Echocardiography showed
large mobile vegetations on tricuspid valve. Initially the
patient was kept on IV antibiotics but her condition kept
on deteriorating with worsening sepsis. At that time
patient was taken to the Operating Room (OR) and
under cardiopulmonary bypass the tricuspid valve was
exposed. The entire tricuspid valve was replaced by
large yellowish mobile vegetations. All three leaflets of
the tricuspid valve were completely resected. Due to
extensive infection at the tricuspid position, no prosthetic
valve was placed. Patient was taken off the cardio-
pulmonary bypass on high inotropic support. After a
prolonged ICU stay in the ICU, patient recovered from
her sepsis and was discharged home in a perfect health.
DISCUSSION
Right sided endocarditis is prototypically characterized
by a mass of platelets, fibrin and colonies of micro-
organism, along with inflammatory cells which add to the
degenerative process. Amongst the intravenous drug
users who present with fever, it has been reported that
most of them have echocardiographic evidence of RSE
involving tricuspid valve and is followed by co-existing
involvement of the mitral and aortic valve.4
The classical presenting complaints of RSE are
persistent fever, bacteremia, sepsis and multiple
pulmonary emboli featuring chest pain, dyspnoea,
cough, and haemoptysis. The triad of bacteremia, fever,
and multiple pulmonary infiltrates on chest radiography
should always prompt an investigation for RSE. Even as
most of the patients of RSE will have a systolic murmur,
it is not distinctively pathologic in the majority of cases.5
The Duke system defines a major echocardiographic
criterion for infective endocarditis as the finding of an
oscillating intracardiac mass on the valve or supporting
structures, in the path of a regurgitant jet, a paravalvular
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abscess or new dehiscence of a prosthetic valve. A few
of the authors have felt that large vegetation size
(diameter > 10 mm) have a chance to benefit from
surgery while others felt that many of the members of
this population will eventually recover with non-surgical,
medical treatment. Very large vegetations (> 20 mm) are
associated with a poor outcome.6
In 1971, first surgical treatment of RSE was reported.7
Over the course of almost 4 decades, the debate has
been directed towards the most successful therapy for
RSE and it has been agreed mostly that surgical option
is only utilized when the medical treatment fails. It has
been reported that patient undergoing tricuspid
valvectomy without replacement following RSE do
generally well. However, 25% of this population usually
develops unbearable tricuspid regurgitation which can
lead to pulmonary hypertension and right-sided heart
failure, which deems valve replacement necessary.
Reconstruction, repair, replacement and mitral valve
homograft have all been reported as surgical options for
RSE. These techniques are readily overtaking the non-
replacement tricuspid valvectomy as they are hemo-
dynamically more stable. If the possibility of valvular
repair is considerably decreased due to the destruction
of the subvalvular apparatus of the anterior leaflet and
since the septal leaflet is rarely implicated, a mitral
homograft can be done.
Given the current rise in trend of IV drug use, it is a fact
that the cases of RSE will also show an increasing trend.
Surgical intervention, in the course of failure of medical
therapy, remains a sound option in the treatment of RSE.
RSE involving the tricuspid valve can be treated with TV
without replacement if the pulmonary arterial pressure is
normal and tricuspid regurgitation does not take place.
This can result in long-term survival of the patient and
late valve replacement can be performed if the extent of
disease does not allow immediate valvuloplasty.
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